The UK medicines cost-effectiveness watchdog has recommended Eli Lilly’s JAK inhibitor Olumiant as a treatment for some people with rheumatoid arthritis (RA). In draft guidance, the National Institute ...

LONDON (Reuters) - In a change of tack, Britain's healthcare cost watchdog NICE has recommended the use of Bristol-Myers Squibb's rheumatoid arthritis drug Orencia by the state health service ...

New Test May Help Patients With RA Avoid Useless Treatment BATTER-UP Consortium will test 8-gene biomarker set for identifying patients with RA who are unlikely to respond to TNF inhibitors. Medscape ...

Price increases for five of the 10 drugs that contributed the most to a rise in U.S. medical spending in 2023 were not supported by clinical evidence and drove costs higher by $815 million, an ...

The Biden administration said Thursday that it had reached an agreement with drugmakers to lower prices on the 10 costliest prescription drugs under Medicare. It's part of the federal government's ...